Dr. Issra E. Jamal, MD

Dr. Jamal practices at Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health.

Dr. Jamal's NPI, 1457792871, was assigned on July 14, 2013. Dr. Jamal graduated from King Abdulaziz University College of Medicine in 2009. Dr. Jamal holds Massachusetts license 287052.

Dr. Jamal's primary practice is Baystate Medical Center, at 759 Chestnut Street, Springfield, MA 01199 in Hampden County. The practice phone is (413) 794-0000.

Dr. Jamal's primary practice is Baystate Medical Center in Springfield, Massachusetts, part of Baystate Health. Dr. Jamal is also affiliated with Baystate Noble Hospital. The medical group on file is Baystate Medical Practices. Dmand AI also links Dr. Jamal to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamal practices, 5 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Jamal's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Jamal is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Jamal's licenses on file in 3 states: Massachusetts, South Carolina and Michigan.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, hypercalcemia, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Jamal treats.

CMS data shows 436 Medicare services from Dr. Jamal across 8 procedure codes in 2024, for 267 Medicare patients. Medicare paid $25,181 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 267 Medicare patients who saw Dr. Jamal in 2024. The largest group is 65 to 74, with 127 patients. 73% of them have high blood pressure, and 69% have high cholesterol. 39% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jamal's median patient age at 68, with 75% women.

In 2024, Dr. Jamal wrote 1,529 Medicare Part D claims for 326 patients. 43% of them were for generic drugs. CMS names the drug for 1,337 of them, across 37 drugs with 11 or more claims each, at $466,958 in total drug cost. In 2023, CMS named 2,684 claims across 48 drugs.

Dr. Jamal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Jamal as offering telehealth.

CMS Open Payments shows 117 general payments to Dr. Jamal from 23 drug and device companies from 2019 to 2021. Food and beverage make up the largest share, 99% of the total. Eli Lilly and Company paid the most, $284.

Dr. Jamal graduated from King Abdulaziz University College of Medicine in 2009.

Dr. Jamal is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.